The ligand for CD40 is expressed on activated T lymphocytes and delivers contact-dependent activation signals to B lymphocytes. The mechanisms regulating CD40 ligand gene expression are largely unknown. Optimal expression of CD40 ligand required activation of protein kinase C and a rise in intracellular calcium concentration. CD40 ligand expression was inhibited by pretreatment of T cells with cyclosporin A. Cyclosporin A analogues inhibited CD40 ligand expression with a potency mirroring the ability of each compound to inhibit calcineurin activity, indicating that calcineurin plays a key role in CD40 ligand gene expression. Cyclosporin A inhibited IL-4-driven CD40 ligand-dependent IgE isotype switching in PBMC but did not inhibit IgE synthesis induced by CD40 mAb plus IL-4. PBMC derived from transplant patients receiving cyclosporin A failed to express CD40 ligand upon stimulation. These results suggest that patients receiving cyclosporin A may be deficient in CD40 ligand-dependent T cell help.
R Fuleihan, N Ramesh, A Horner, D Ahern, P J Belshaw, D G Alberg, I Stamenkovic, W Harmon, R S Geha
Title and authors | Publication | Year |
---|---|---|
Monoclonal antibody-mediated immunosuppression enables long-term survival of transplanted human neural stem cells in mouse brain.
McGinley LM, Chen KS, Mason SN, Rigan DM, Kwentus JF, Hayes JM, Glass ED, Reynolds EL, Murphy GG, Feldman EL |
Clinical and Translational Medicine | 2022 |
Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154+ Aspergillus fumigatus specific T-cell quantification
L Page, CD Lauruschkat, J Helm, P Weis, M Lazariotou, H Einsele, AJ Ullmann, J Loeffler, S Wurster |
Medical Microbiology and Immunology | 2020 |
Clinical and molecular features of X-linked hyper IgM syndrome – An experience from North India
A Rawat, B Mathew, V Pandiarajan, A Jindal, M Sharma, D Suri, A Gupta, S Goel, A Karim, B Saikia, RW Minz, K Imai, S Nonoyama, O Ohara, SC Giliani, LD Notarangelo, KW Chan, YL Lau, S Singh |
Clinical Immunology | 2018 |
CD40LG duplication-associated autoimmune disease is silenced by nonrandom X-chromosome inactivation
CL Coz, M Trofa, CM Syrett, A Martin, H Jyonouchi, S Jyonouchi, MC Anguera, N Romberg |
Journal of Allergy and Clinical Immunology | 2018 |
The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management
R Yazdani, S Fekrvand, S Shahkarami, G Azizi, B Moazzami, H Abolhassani, A Aghamohammadi |
Clinical Immunology | 2018 |
Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study
MJ Bottomley, M Chen, S Fuggle, PN Harden, KJ Wood |
Transplantation Direct | 2017 |
Kelley and Firestein's Textbook of Rheumatology
PE di Cesare, DR Haudenschild, J Samuels, SB Abramson |
Kelley and Firestein's Textbook of Rheumatology | 2017 |
Lupus
WA Khan |
Lupus | 2017 |
Scaffold protein JLP mediates TCR-initiated CD4 + T cell activation and CD154 expression
Q Yan, C Yang, Q Fu, Z Chen, S Liu, D Fu, RN Rahman, R Nakazato, K Yoshioka, SK Kung, G Ding, H Wang |
Molecular Immunology | 2017 |
Immunosuppressive Compounds Exhibit Particular Effects on Functional Properties of Human Anti-Aspergillus TH1 Cells
L Tramsen, S Schmidt, F Roeger, R Schubert, E Salzmann-Manrique, JP Latge, T Klingebiel, T Lehrnbecher |
Infection and immunity | 2014 |
Unique B cell differentiation profile in tolerant kidney transplant patients
M Chesneau, A Pallier, F Braza, G Lacombe, SL Gallou, D Baron, M Giral, R Danger, P Guerif, H Aubert-Wastiaux, A Néel, L Michel, DA Laplaud, N Degauque, JP Soulillou, K Tarte, S Brouard |
American Journal of Transplantation | 2013 |
Impaired NFAT and NFκB Activation are Involved in Suppression of CD40 Ligand Expression by Δ9-Tetrahydrocannabinol in Human CD4+ T cells
T Ngaotepprutaram, BL Kaplan, NE Kaminski |
Toxicology and Applied Pharmacology | 2013 |
The Hyper IgM Syndromes
N Qamar, RL Fuleihan |
Clinical Reviews in Allergy & Immunology | 2013 |
Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation
YW Zhang, HW Zhao, X He, SW Zheng, TH Wang, DL Yan, JF Sun, X Lu, JF Wen, WY Lau |
Science China Life Sciences | 2012 |
Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells
T Ngaotepprutaram, BL Kaplan, RB Crawford, NE Kaminski |
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology | 2012 |
Human CD14hi monocytes and myeloid dendritic cells provide a cell contact–dependent costimulatory signal for early CD40 ligand expression
S Chakrabarty, JT Snyder, J Shen, H Azmi, PQ Hu, Q Chen, JA Ragheb |
Blood | 2011 |
Cyclosporine-Resistant, Rab27a-Independent Mobilization of Intracellular Preformed CD40 Ligand Mediates Antigen-Specific T Cell Help In Vitro
Y Koguchi, JL Gardell, TJ Thauland, DC Parker |
Journal of immunology (Baltimore, Md. : 1950) | 2011 |
Immunosuppressive activities of water-soluble barley β-glucan on alloantigen reactive cell proliferation and cytotoxicity
DS Ryu, SH Kim, SM Oh, HS Lee, JH Jeong, SH Kim, DS Lee |
Food Science and Biotechnology | 2011 |
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné |
Advances in Immunology Volume 110 | 2011 |
Pharmacodynamic Monitoring of Calcineurin Inhibition Therapy: Principles, Performance, and Perspectives
HH van Rossum, JW de Fijter, J Pelt |
Therapeutic Drug Monitoring | 2010 |
Kelley's Textbook of Rheumatology
J Degroot, AM Zuurmond, PP Tak |
Kelley's Textbook of Rheumatology | 2009 |
Functional analysis of a tripartite stability element within the CD40 ligand 3' untranslated region
J Laughlin, S Oghlidos, JF Porter, R Matus-Nicodemos, FL Sinquett, V Marcelli, LR Covey |
Immunology | 2008 |
Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature
HJ Kim, YK Hong, WH Yoo |
Rheumatology International | 2008 |
Promises and Obstacles for the Blockade of CD40–CD40L Interactions in Allotransplantation
XL Li, S Ménoret, BL Mauff, M Angin, I Anegon |
Transplantation | 2008 |
Deregulated expression of CD40 ligand in HTLV-I infection: Distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients
NS Harhaj, B Janic, JC Ramos, WJ Harrington, EW Harhaj |
Virology | 2007 |
Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion
EB Alabraba, V Lai, L Boon, SJ Wigmore, DH Adams, SC Afford |
Hepatology | 2007 |
Luteolin, a Flavonoid, Inhibits CD40 Ligand Expression by Activated Human Basophils
T Hirano, J Arimitsu, S Higa, T Naka, A Ogata, Y Shima, M Fujimoto, T Yamadori, T Ohkawara, Y Kuwabara, M Kawai, I Kawase, T Tanaka |
International Archives of Allergy and Immunology | 2006 |
Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity
A Bavandi, H Fahrngruber, H Aschauer, B Hartmann, JG Meingassner, FS Kalthoff |
Journal of Dermatological Science | 2006 |
Luteolin, a flavonoid, inhibits AP-1 activation by basophils
T Hirano, S Higa, J Arimitsu, T Naka, A Ogata, Y Shima, M Fujimoto, T Yamadori, T Ohkawara, Y Kuwabara, M Kawai, H Matsuda, M Yoshikawa, N Maezaki, T Tanaka, I Kawase, T Tanaka |
Biochemical and Biophysical Research Communications | 2006 |
Nonsteroid Immune Modulators and Bone Disease
R Tamler |
Annals of the New York Academy of Sciences | 2006 |
Development and Validation of a Canine T-Cell-Dependent Antibody Response Model for Immunotoxicity Evaluation
D Finco-Kent, TT Kawabata |
Journal of Immunotoxicology | 2005 |
Rationale for T Cell Inhibition by Cyclosporin A in Major Autoimmune Diseases
G Ferraccioli, P Tomietto, M Santis |
Annals of the New York Academy of Sciences | 2005 |
Bone Disease of Organ Transplantation
MR Rubin, JP Billezkian |
Bone Disease of Organ Transplantation | 2005 |
Immunotherapy Targeting the CD40/CD154 Costimulatory Pathway for Treatment of Autoimmune Disease
LM Howard, SD Miller |
Autoimmunity | 2004 |
Targeting CD40L: a promising therapeutic approach
D Daoussis, AP Andonopoulos, SN Liossis |
Clinical and diagnostic laboratory immunology | 2004 |
Costimulation Blockade in the Treatment of Rheumatic Diseases:
SN Liossis, PP Sfikakis |
BioDrugs | 2004 |
Analysis of Intragraft Gene and Protein Expression of the Costimulatory Molecules, CD80, CD86 and CD154, in Orthotopic Liver Transplant Recipients
AS Bartlett, JL McCall, R Ameratunga, ML Yeong, E Gane, SR Munn |
American Journal of Transplantation | 2003 |
Major Peptide Autoepitopes for Nucleosome-Centered T and B Cell Interaction in Human and Murine Lupus
SK Datta |
Annals of the New York Academy of Sciences | 2003 |
Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood
MJ Barten, S Dhein, H Chang, HB Bittner, A Tarnok, A Rahmel, FW Mohr, JF Gummert |
Journal of Immunological Methods | 2003 |
CD154 expression and mRNA stability of activated CD4-positive T cells in patients with systemic lupus erythematosus
M Takaya, N Tamura, K Kato, S Kobayashi, K Haruta, M Tajima, M Hara, KS Yang, H Tsuda, H Hashimoto |
Modern Rheumatology | 2003 |
Delineation of a Novel Pathway That Regulates CD154 (CD40 Ligand) Expression
BJ Hamilton, A Genin, RQ Cron, WF Rigby |
Molecular and cellular biology | 2003 |
Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression
S Skov, K Rieneck, LF Bovin, K Skak, S Tomra, BK Michelsen, N Ødum |
Blood | 2003 |
SεSμ and SεSγ Switch Circles in Human Nasal Mucosa Following Ex Vivo Allergen Challenge: Evidence for Direct as Well as Sequential Class Switch Recombination
L Cameron, AS Gounni, S Frenkiel, F Lavigne, D Vercelli, Q Hamid |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
CD154 Transcriptional Regulation in Primary Human CD4 T Cells
RQ Cron |
Immunologic Research | 2003 |
New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs
M Sho, SE Sandner, N Najafian, AD Salama, V Dong, A Yamada, K Kishimoto, H Harada, I Schmitt, MH Sayegh |
Annals of Surgery | 2002 |
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo
A Bergamini, M Cepparulo, F Bolacchi, A Araco, G Tisone, D Ombres, G Rocchi, M Angelico |
Clinical & Experimental Immunology | 2002 |
CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition
CG Katsiari, SN Liossis, AM Dimopoulos, DV Charalambopoulos, M Mavrikakis, PP Sfikakis |
Lupus | 2002 |
Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat
A Bartlett |
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society | 2002 |
CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation:
MM van Rijen, ML Kuijf, HJ Metselaar, HW Tilanus, GJ Bouma, RA de Weger, M Jonker, J Kwekkeboom |
Transplantation | 2002 |
Glucocorticoids upregulate CD40 ligand (CD40L) expression and induce CD40L dependent immunoglobulin isotype switching
Haifa H. Jabara, Scott R. Brodeur, Raif S. Geha |
Journal of Clinical Investigation | 2001 |
Regulation of CD40 ligand expression in systemic lupus erythematosus
MK Crow, KA Kirou |
Current Opinion in Rheumatology | 2001 |
Tissue Distribution of Calcineurin and its Sensitivity to Inhibition by Cyclosporine
L Kung, TD Batiuk, S Palomo-Pinon, J Noujaim, LM Helms, PF Halloran |
American Journal of Transplantation | 2001 |
Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway
JD Fayen |
Immunology | 2001 |
Effect of trapidil on effector functions of monocytes related to atherosclerotic plaque
Y Kato, T Tsuda, Y Hosaka, T Takahashi, K Shirakawa, S Furusako, K Mizuguchi, H Mochizuki |
European Journal of Pharmacology | 2001 |
The role of CD154 in organ transplant rejection and acceptance
PJ Morris, KJ Wood, AD Kirk, PJ Blair, DK Tadaki, H Xu, DM Harlan |
Philosophical Transactions of The Royal Society B Biological Sciences | 2001 |
Conventional immunosuppression and co-stimulation blockade
PJ Morris, KJ Wood, AB Adams, TC Pearson, CP Larsen |
Philosophical Transactions of The Royal Society B Biological Sciences | 2001 |
Role of T Cells and Gamma Interferon during Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock Syndrome Toxin 1 in Mice
JD Clements, MM Dinges, PM Schlievert |
Infection and immunity | 2001 |
CD154 (CD40 ligand)
U Schönbeck, F Mach, P Libby |
The International Journal of Biochemistry & Cell Biology | 2000 |
Interleukin-15 up-regulates the expression of CD154 on synovial fluid T cells
M Möttönen, P Isomäki, R Luukkainen, P Toivanen, J Punnonen, O Lassila |
Immunology | 2000 |
CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
PJ Blair, JL Riley, DM Harlan, R Abe, DK Tadaki, SC Hoffmann, L White, T Francomano, SJ Perfetto, AD Kirk, CH June |
Journal of Experimental Medicine | 2000 |
Transcriptional Activity of the Distal CD40 Ligand Promoter
FM Lobo, S Xu, C Lee, RL Fuleihan |
Biochemical and Biophysical Research Communications | 2000 |
Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers
H Amano, S Morimoto, H Kaneko, Y Tokano, Y Takasaki, H Hashimoto |
Lupus | 2000 |
DIFFERENTIAL EFFECTS OF CYCLOSPORINE A, METHYLPREDNISOLONE, MYCOPHENOLATE, AND RAPAMYCIN ON CD154 INDUCTION AND REQUIREMENT FOR NF??B: Implications for Tolerance Induction1
ST Smiley, V Csizmadia, W Gao, LA Turka, WW Hancock |
Transplantation | 2000 |
HIGH-DOSE PORCINE HEMATOPOIETIC CELL TRANSPLANTATION COMBINED WITH CD40 LIGAND BLOCKADE IN BABOONS PREVENTS AN INDUCED ANTI-PIG HUMORAL RESPONSE:
L Bhler, M Awwad, M Basker, S Gojo, A Watts, S Treter, K Nash, G Oravec, Q Chang, A Thall, JD Down, M Sykes, D Andrews, R Sackstein, ME White-Scharf, DH Sachs, DK Cooper |
Transplantation | 2000 |
Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells
Y Yi, M McNerney, SK Datta |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
CD81 and CD28 Costimulate T Cells Through Distinct Pathways
DA Witherden, R Boismenu, WL Havran |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
IL-2 and IL-15 Regulate CD154 Expression on Activated CD4 T Cells
S Skov, M Bonyhadi, N Ødum, JA Ledbetter |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Identification of a Complex that Binds to the CD154 3′ Untranslated Region: Implications for a Role in Message Stability During T Cell Activation
B Barnhart, PA Kosinski, Z Wang, GS Ford, M Kiledjian, LR Covey |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Blocking CD40 – CD154 and CD80/CD86 – CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production
SW van Gool, J Vermeiren, K Rafiq, K Lorré, M Boer, JL Ceuppens |
European Journal of Immunology | 1999 |
Regulatory Effects of Cytokines and Cyclosporine A on Peripheral Blood Mononuclear Cs from Stable Multiple Sclerosis Patients
C Guillen, A Prieto, JC Alvarez-Cermeño, M la Piedra, A Gimeno, M Alvarez-Mon |
Immunopharmacology and Immunotoxicology | 1999 |
Abnormal Functiuonal Behavior of Peripheral Blood Mononuclear Cells from Hashimoto's Disease Patients. Immunomodulatory Effects of Cyclosporin A
C Guillen, A Prieto, CA Escola, E Reyes, D Diaz, E Sanantonio, AD la Hera, MA Mon |
Immunopharmacology and Immunotoxicology | 1999 |
The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents
O Jirapongsananuruk, DY Leung |
Clinical & Experimental Immunology | 1999 |
Transfer of activation-dependent gene expression into T cell lines by recombinant adeno-associated virus
PX Zhang, RL Fuleihan |
Gene Therapy | 1999 |
HUMAN T CELL RESPONSES TO HUMAN AND PORCINE ENDOTHELIAL CELLS ARE HIGHLY SENSITIVE TO CYCLOSPORIN A AND FK506 IN VITRO1:
P Batten, AM McCormack, CS Page, MH Yacoub, ML Rose |
Transplantation | 1999 |
THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1:
PF Halloran, LM Helms, L Kung, J Noujaim |
Transplantation | 1999 |
The hyper-IgM (HIM) syndrome
N Ramesh, M Seki, LD Notarangelo, RS Geha |
Springer Seminars in Immunopathology | 1998 |
Paediatric kidney transplantation
J Laine, H Jalanko, K Ronnholm, H Sairanen, K Salmela, M Leijala, C Holmberg |
Annals of Medicine | 1998 |
Medication induced gingival overgrowth
RI Marshall, PM Bartold |
Oral Diseases | 1998 |
The gingival plasma cell infiltrate in renal transplant patients on an immunosuppressive regime
KS Krist |
Acta Odontologica Scandinavica | 1998 |
Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen
AR Gennery, AJ Cant, GP Spickett, D Walshaw, S Hunter, A Hasan, JR Hamilton, J Dark |
The Lancet | 1998 |
Utilization of an NF-ATp binding promoter element for EGR3 expression in T cells but not fibroblasts provides a molecular model for the lymphoid cell-specific effect of cyclosporin A
HW Mages, R Baag, B Steiner, RA Kroczek |
Molecular and cellular biology | 1998 |
Evidence for a Type 2 Bias in the CD8+ T-Cell Response to Epstein-Barr Virus Following Heart Transplantation
MJ Cannon, LD Reed, K Mawulawde |
Transplantation Proceedings | 1998 |
Glucocorticoids Inhibit CD40 Ligand Expression of Peripheral CD4+Lymphocytes
F Bischof, A Melms |
Cellular Immunology | 1998 |
THE USE OF NEORAL IN RHEUMATOID ARTHRITIS
A Cranney, P Tugwell |
Rheumatic Disease Clinics of North America | 1998 |
Evidence that calcineurin is rate-limiting for primary human lymphocyte activation
TD Batiuk, L Kung, PF Halloran |
Journal of Clinical Investigation | 1997 |
Osteoporosis
DL Glaser, FS Kaplan |
Spine | 1997 |
Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients
V Thon, HM Wolf, M Sasgary, J Litzman, A Samstag, I Hauber, J Lokaj, MM Eibl |
Clinical & Experimental Immunology | 1997 |
Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand. Involvement of transcriptional and posttranscriptional mechanisms
A Suárez, L Mozo, A Gayo, J Zamorano, C Gutierrez |
European Journal of Immunology | 1997 |
Calcineurin-dependent nuclear translocation of a murine transcription factor NFATx: molecular cloning and functional characterization
J Liu, N Koyano-Nakagawa, Y Amasaki, F Saito-Ohara, T Ikeuchi, S Imai, T Takano, N Arai, T Yokota, K Arai |
Molecular biology of the cell | 1997 |
Cyclosporin A in Hyperimmunoglobulin E Syndrome
A Etzioni, N Shehadeh, A Brecher, S Yorman, S Pollack |
Annals of Allergy Asthma & Immunology | 1997 |
Effects of the Immunosuppressive Drugs CsA and FK506 on Intracellular Signalling and Gene Regulation
A Rühlmann, A Nordheim |
Immunobiology | 1997 |
Molecular Cloning and Functional Characterization of Murine cDNA Encoding Transcription Factor NFATc
S Pan, N Koyano-Nakagawa, L Tsuruta, Y Amasaki, T Yokota, S Mori, N Arai, K Arai |
Biochemical and Biophysical Research Communications | 1997 |
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
M Koshy, D Berger, MK Crow |
Journal of Clinical Investigation | 1996 |
Pharmacology of immunosuppressive medications used in renal diseases and transplantation
AM de Mattos, AJ Olyaei, WM Bennett |
American Journal of Kidney Diseases | 1996 |
Genomic structure and PCR-SSCP analysis of the human CD40 ligand gene: Its application to prenatal screening for X-linked hyper-IgM syndrome
K Seyama, S Kira, K Ishidoh, S Souma, T Miyakawa, E Kominami |
Human Genetics | 1996 |
IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39
TM Foy, A Aruffo, J Bajorath, JE Buhlmann, RJ Noelle |
Annual Review of Immunology | 1996 |
Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells
B Ludewig, V Henn, JM Schröder, D Graf, RA Kroczek |
European Journal of Immunology | 1996 |
Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway
K Karmann, CC Hughes, WC Fanslow, JS Pober |
European Journal of Immunology | 1996 |
The CD40L Promoter Contains Nuclear Factor of Activated T Cells-binding Motifs Which Require AP-1 Binding for Activation of Transcription
AV Tsytsykova, EN Tsitsikov, RS Geha |
The Journal of biological chemistry | 1996 |
Blood Cell Biochemistry
AD Whetton, J Gordon |
1996 | |
CD40-mediated lymphotoxin α expression in human B cells is tyrosine kinase dependent
M Worm, RS Geha |
European Journal of Immunology | 1995 |
gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes
AA Horner, H Jabara, N Ramesh, RS Geha |
Journal of Experimental Medicine | 1995 |
NFATc3, a Lymphoid-specific NFATc Family Member That Is Calcium-regulated and Exhibits Distinct DNA Binding Specificity
SN Ho, DJ Thomas, LA Timmerman, X Li, U Francke, GR Crabtree |
The Journal of biological chemistry | 1995 |
The Human gp39 Promoter
LA Schubert, G King, RQ Cron, DB Lewis, A Aruffo, D Hollenbaugh |
The Journal of biological chemistry | 1995 |
Clinical Use of Cyclosporin in Rheumatoid Arthritis:
C Richardson, P Emery |
Drugs | 1995 |
Decreased expression of the ligand for CD40 in newborn lymphocytes
R Fuleihan, D Ahern, RS Geha |
European Journal of Immunology | 1994 |
Structure of the murine CD40 ligand gene
EN Tsitsikov, N Ramesh, RS Geha |
Molecular Immunology | 1994 |
Protein Tyrosine Kinase Activation and Protein Kinase C Translocation Are Functional Components of CD40 Signal Transduction in Resting Human B Cells
CL Ren, SM Fu, RS Geha |
Immunological Investigations | 1994 |
CD40-mediated regulation of human B-cell responses
JB Splawski, PE Lipsky |
Research in Immunology | 1994 |
Advances in Genetics
BH Bowman, F Yang, GS Adrian |
Advances in genetics | 1988 |